157 related articles for article (PubMed ID: 26361747)
1. An analysis of the relative frequencies of reported adverse events associated with NSAID administration in dogs and cats in the United Kingdom.
Hunt JR; Dean RS; Davis GN; Murrell JC
Vet J; 2015 Nov; 206(2):183-90. PubMed ID: 26361747
[TBL] [Abstract][Full Text] [Related]
2. The attitudes of owners and veterinary professionals in the United Kingdom to the risk of adverse events associated with using non-steroidal anti-inflammatory drugs (NSAIDs) to treat dogs with osteoarthritis.
Belshaw Z; Asher L; Dean RS
Prev Vet Med; 2016 Sep; 131():121-126. PubMed ID: 27544261
[TBL] [Abstract][Full Text] [Related]
3. Toxicology of frequently encountered nonsteroidal anti-inflammatory drugs in dogs and cats.
Khan SA; McLean MK
Vet Clin North Am Small Anim Pract; 2012 Mar; 42(2):289-306, vi-vii. PubMed ID: 22381180
[TBL] [Abstract][Full Text] [Related]
4. Nonsteroidal anti-inflammatory drug toxicosis in dogs and cats: 240 cases (1989-1990).
Jones RD; Baynes RE; Nimitz CT
J Am Vet Med Assoc; 1992 Aug; 201(3):475-7. PubMed ID: 1506258
[TBL] [Abstract][Full Text] [Related]
5. Toxicology of Frequently Encountered Nonsteroidal Anti-inflammatory Drugs in Dogs and Cats: An Update.
McLean MK; Khan SA
Vet Clin North Am Small Anim Pract; 2018 Nov; 48(6):969-984. PubMed ID: 30149968
[TBL] [Abstract][Full Text] [Related]
6. Veterinary Products Committee working group report on feline and canine vaccination.
Gaskell RM; Gettinby G; Graham SJ; Skilton D
Vet Rec; 2002 Feb; 150(5):126-34. PubMed ID: 11871665
[TBL] [Abstract][Full Text] [Related]
7. Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs.
Hur C; Chan AT; Tramontano AC; Gazelle GS
Ann Pharmacother; 2006 Jun; 40(6):1052-63. PubMed ID: 16720709
[TBL] [Abstract][Full Text] [Related]
8. Toxicology of nonsteroidal antiinflammatory drugs.
Kore AM
Vet Clin North Am Small Anim Pract; 1990 Mar; 20(2):419-30. PubMed ID: 2180187
[TBL] [Abstract][Full Text] [Related]
9. NSAID-induced gastrointestinal damage: current clinical management and recommendations for prevention.
Lanas A; Ferrandez A
Chin J Dig Dis; 2006; 7(3):127-33. PubMed ID: 16808792
[TBL] [Abstract][Full Text] [Related]
10. The renal effects of NSAIDs in dogs.
Lomas AL; Grauer GF
J Am Anim Hosp Assoc; 2015; 51(3):197-203. PubMed ID: 25955147
[TBL] [Abstract][Full Text] [Related]
11. New approaches to pharmacosurveillance for monitoring prescription frequency, diversity, and co-prescription in a large sentinel network of companion animal veterinary practices in the United Kingdom, 2014-2016.
Singleton DA; Sánchez-Vizcaíno F; Arsevska E; Dawson S; Jones PH; Noble PJM; Pinchbeck GL; Williams NJ; Radford AD
Prev Vet Med; 2018 Nov; 159():153-161. PubMed ID: 30314778
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology, safety, efficacy and clinical uses of the COX-2 inhibitor robenacoxib.
Lees P; Toutain PL; Elliott J; Giraudel JM; Pelligand L; King JN
J Vet Pharmacol Ther; 2022 Jul; 45(4):325-351. PubMed ID: 35460083
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic drug use in treatment of dogs and cats with cancer by UK veterinary practices (2003 to 2004).
Cave TA; Norman P; Mellor D
J Small Anim Pract; 2007 Jul; 48(7):371-7. PubMed ID: 17559520
[TBL] [Abstract][Full Text] [Related]
14. Adverse reactions from essential oil-containing natural flea products exempted from Environmental Protection Agency regulations in dogs and cats.
Genovese AG; McLean MK; Khan SA
J Vet Emerg Crit Care (San Antonio); 2012 Aug; 22(4):470-5. PubMed ID: 22805458
[TBL] [Abstract][Full Text] [Related]
15. Channeling and prevalence of cardiovascular contraindications in users of cyclooxygenase 2 selective nonsteroidal antiinflammatory drugs.
Mosis G; Stijnen T; Castellsague J; Dieleman JP; van der Lei J; Stricker BH; Sturkenboom MC
Arthritis Rheum; 2006 Aug; 55(4):537-42. PubMed ID: 16874797
[TBL] [Abstract][Full Text] [Related]
16. [Insight on the clinical pharmacology of non-steroidal anti-inflammatory drugs].
Maddison JE
Tijdschr Diergeneeskd; 2010 Jan; 135(2):54-8. PubMed ID: 20344966
[No Abstract] [Full Text] [Related]
17. Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk.
Moore RA; Derry S; McQuay HJ
BMC Musculoskelet Disord; 2007 Aug; 8():73. PubMed ID: 17683540
[TBL] [Abstract][Full Text] [Related]
18. Upper gastrointestinal symptoms and therapies in elderly out-patients, users of non-selective NSAIDs or coxibs.
Pilotto A; Franceschi M; Vitale DF; Zaninelli A; Masotti G; Rengo F; ;
Aliment Pharmacol Ther; 2005 Jul; 22(2):147-55. PubMed ID: 16011673
[TBL] [Abstract][Full Text] [Related]
19. Precautions when using antiprostaglandins.
Cribb PH
Vet Clin North Am Small Anim Pract; 1992 Mar; 22(2):370-4. PubMed ID: 1585581
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.
Solomon DH; Avorn J; Stürmer T; Glynn RJ; Mogun H; Schneeweiss S
Arthritis Rheum; 2006 May; 54(5):1378-89. PubMed ID: 16645966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
